Floating Drug Delivery System an Aid to Enhance Dissolution Profile of Gastric

  • SHALINI YADAV Dr. M.C. Saxena College of Pharmacy, IIM Road-Lucknow, Uttar-Pradesh, India https://orcid.org/0000-0001-6667-3935
  • SAURAV YADAV Dr. M.C. Saxena College of Pharmacy, IIM Road-Lucknow, Uttar-Pradesh, India https://orcid.org/0000-0002-0521-1339
  • ASHUTOSH KUMAR Dr. M.C. Saxena College of Pharmacy, IIM Road-Lucknow, Uttar-Pradesh, India
  • AMAR MISHRA Dr. M.C. Saxena College of Pharmacy, IIM Road-Lucknow, Uttar-Pradesh, India

Abstract

With the GRDDS, the dose shape remains controllably in the stomach after oral administration, so that the medication may be continually delivered to its absorption receptors in the intestinal tract. The medicine is delivering in a controlled and extended way. Gastro-retentive dose in the stomach area may last for another few hours and substantially lengthen the gastric residence period of the medicines. While the bulk density in the system for the supply of floating medicines (FDDS) exceeds the gastric fluids, it remains for an extended duration in the stomach without altering the rate of decomposition. The medication distributes gradually as the system floats on the stomach juice. As a consequence, stomach residency takes longer and plasma concentrations are well monitored. The therapy of peptic ulcer illness might be beneficial for local activity in the upper portion of the intestine, i.e., a longer stomach residency. In addition, medicines rapidly absorbed in the GI tract will increase bioavailability through delayed stomach release. The regulated gastric retention of solid dose forms can also be accomplished by the simultaneous administration of pharmacological agents, or by sedimentation, flotation processes, muco-adhesion, expansion, changed shape systems, by delaying the stomach emptying.


Keywords: Gastro-retentive drug delivery system, Floating drug delivery system, Muco-adhesion, Bioavailability.

Keywords: Gastro-retentive drug delivery system, Floating drug delivery system, Muco-adhesion, Bioavailability

Downloads

Download data is not yet available.

Author Biographies

SHALINI YADAV, Dr. M.C. Saxena College of Pharmacy, IIM Road-Lucknow, Uttar-Pradesh, India

Dr. M.C. Saxena College of Pharmacy, IIM Road-Lucknow, Uttar-Pradesh, India

SAURAV YADAV, Dr. M.C. Saxena College of Pharmacy, IIM Road-Lucknow, Uttar-Pradesh, India

Dr. M.C. Saxena College of Pharmacy, IIM Road-Lucknow, Uttar-Pradesh, India

ASHUTOSH KUMAR, Dr. M.C. Saxena College of Pharmacy, IIM Road-Lucknow, Uttar-Pradesh, India

Dr. M.C. Saxena College of Pharmacy, IIM Road-Lucknow, Uttar-Pradesh, India

AMAR MISHRA, Dr. M.C. Saxena College of Pharmacy, IIM Road-Lucknow, Uttar-Pradesh, India

Dr. M.C. Saxena College of Pharmacy, IIM Road-Lucknow, Uttar-Pradesh, India

References

1- Dubey, J., & Verma, N. Floating drug delivery system: a review: International Journal of Pharmaceutical Sciences and Research, 2013; 4(8):2893.
2- Niharika, M. G., Krishnamoorthy, K. A. N. N. A. N., & Akkala, M. A. D. H. U. K. A. R. Overview on floating drug delivery system: Int J App Pharm, 2018; 10(6):65-71. https://doi.org/10.22159/ijap.2018v10i6.28274
3- Deshpande, A. A., Rhodes, C. T., Shah, N. H., & Malick, A. W. Controlled-release drug delivery systems for prolonged gastric residence: an overview: Drug Development and Industrial Pharmacy, 1996; 2(6):531-539. https://doi.org/10.3109/03639049609108355
4- Whitehead, L., Fell, J. T., & Collett, J. H. Development of gastro-retentive dosage form: European Journal of Pharmaceutical Sciences, 1996; (4S):182. https://doi.org/10.1016/S0928-0987(97)86558-X
5- SOPYAN, I., & WAHYUNINGRUM, R. A review: Floating drug delivery system as a tool to improve dissolution rate in gastric: International Journal of Applied Pharmaceutics, 2020:51-54. https://doi.org/10.22159/ijap.2020v12i4.38415
6- Garg, S., & Sharma, S. Gastro-retentive drug delivery systems. Business Briefing: Pharma-tech, 2003; 5(2).
7- Vedha, H., & Chaudhary, J. The recent developments on gastric floating drug delivery system: An overview. Journal of Pharmaceutical Technology and Research, 2010; 2(1):524-34.
8- Dangi, S., Chakraborty, A. K., & GANJU, K. Recent Technological Approaches on Floating Drug Delivery System: International Journal on Current Trends in Drug Development & Industrial Pharmacy; 2017; 1(1)2581-7655 (online)].
9- Arora, S., Ali, J., Ahuja, A., Khar, R. K., & Baboota, S. Floating drug delivery systems: a review: AAPS Pharm-SciTech, 2005; 6(3):E372-E390. https://doi.org/10.1208/pt060347
10- Chavanpatil, M. D., Jain, P., Chaudhari, S., Shear, R., & Vavia, P. R. Novel sustained release, swellable and bioadhesive gastroretentive drug delivery system for ofloxacin: International journal of pharmaceutics, 2006; 316(1-2):86-92. https://doi.org/10.1016/j.ijpharm.2006.02.038
11- Klausner, E. A., Lavy, E., Friedman, M., & Hoffman, A. Expandable gastro-retentive dosage forms: Journal of controlled release, 2003; 90(2): 143-162. https://doi.org/10.1016/S0168-3659(03)00203-7
12- Joshi, P., Patel, P., Modi, H., Patel, M. R., Patel, K. R., & Patel, N. M. (2012). A review on gastro-retentive drug delivery system: Journal of Pharmaceutical Science and Bioscientific Research, 2012; 2(3):123-128.
13- Singh, B. N., & Kim, K. H. Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention: Journal of Controlled release, 2000; 63(3):235-259. https://doi.org/10.1016/S0168-3659(99)00204-7
14- Desai, S., & Bolton, S. A floating controlled-release drug delivery system: in vitro-in vivo evaluation: Pharmaceutical research, 1993; 10(9):1321-1325. https://doi.org/10.1023/A:1018921830385
15- Umamaheshwari, R. B., Jain, S., Bhadra, D., & Jain, N. K. Floating microspheres bearing acetohydroxamic acid for the treatment of Helicobacter pylori: Journal of pharmacy and pharmacology, 2003; 55(12):1607-1613. https://doi.org/10.1211/0022357022223
16- Jain, S. K., Awasthi, A. M., Jain, N. K., & Agrawal, G. P. Calcium silicate-based microspheres of repaglinide for gastro-retentive floating drug delivery: Preparation and in vitro characterization: Journal of controlled release, 2005; 107(2):300-309. https://doi.org/10.1016/j.jconrel.2005.06.007
17- Syan, N., Mathur, P., Saroha, K., Verma, S., & Kumar, V. Floating drug delivery system: An innovative acceptable approach in gastro-retentive drug delivery: Arch. Apll. Sci. Res, 2010; 2(2): 57-270.
18- Sopyan, I., & Wahyuningrum, R. A review: Floating drug delivery system as a tool to improve dissolution rate in gastric: International Journal of Applied Pharmaceutics, 2020: 51-54. https://doi.org/10.22159/ijap.2020v12i4.38415
19- Chandel, A., Chauhan, K., Parashar, B., Kumar, H., & Arora, S. Floating drug delivery systems: A better approach: International Current Pharmaceutical Journal, 2012; 1(5):119-127. https://doi.org/10.3329/icpj.v1i5.10283
20- Shah, S. H., Patel, J. K., & Patel, N. V. Stomach specific floating drug delivery system: A review. Int J Pharm Tech Res, 2009; 1(3):623-33.
21- Hwang, S. J., Park, H., & Park, K. Gastric retentive drug-delivery systems: Critical Reviews™ in Therapeutic Drug Carrier Systems, 1998; 15(3). https://doi.org/10.1615/CritRevTherDrugCarrierSyst.v15.i3.20
22- Gopalakrishnan, S., & Chenthilnathan, A. Floating drug delivery systems: A Review: Journal of Pharmaceutical Science and Technology, 2011; 3(2):548-554.
23- Vedha, H., & Chaudhary, J. The recent developments on gastric floating drug delivery system: An overview: Journal of Pharmaceutical Technology and Research, 2010; 2(1):524-34.
24- Silang, R., Regalado, M., Cheng, T. H., & Wesson, D. E. Prokinetic agents increase plasma albumin in hypoalbuminemic chronic dialysis patients with delayed gastric emptying: American journal of kidney diseases, 2001; 37(2):287-293. https://doi.org/10.1053/ajkd.2001.21291
25- Kamalakkannan, V., Puratchikody, A., Prasanth, V. V., & Masilamani, K. Enhancement of drugs bioavailability by floating drug delivery system-A review: International Journal of Drug Delivery, 2011; 3(4):558.
26- Suryawanshi, A., & Hiremath, S. P. Floating Drug Delivery System-A Review: American Journal of Pharmatech Research, 2011; 2(1):138-53.
27- Mantry, S., Thilothama, L. R., & Shashanka, D. Formulation and in vitro evaluation of metoprolol succinate floating tablets by using two viscosity grades of HPMC: International Journal of Pharmaceutical Sciences and Research, 2012; 3(9):3507.
28- Hwang, S. J., Park, H., & Park, K. Gastric retentive drug-delivery systems: Critical Reviews™ in Therapeutic Drug Carrier Systems, 1998; 15(3). https://doi.org/10.1615/CritRevTherDrugCarrierSyst.v15.i3.20
29- Sabale, V., Sakarkar, S., Pund, S., & Sabale, P. Formulation and evaluation of floating dosage forms: An overview. Systematic Reviews in Pharmacy, 2010; 1(1):33. https://doi.org/10.4103/0975-8453.59510
30- Datir, S. K., Patil, P. B., & Saudagar, R. B. Floating type drug delivery system: a review: Journal of Drug Delivery and Therapeutics, 2019; 9(2):428-432. https://doi.org/10.22270/jddt.v9i2.2492
31- Rocca, J. G., Omidian, H., & Shah, K. Progresses in gastro-retentive drug delivery systems. Business Briefing: Pharma Tech, 2003; 152-156.
32- Menon, A., Ritschel, W. A., & Sakr, A. Development and evaluation of a monolithic floating dosage form for furosemide: Journal of pharmaceutical sciences, 1994; 83(2):239-245. https://doi.org/10.1002/jps.2600830225
33- Oth, M., Franz, M., Timmermans, J., & Möes, A. The bilayer floating capsule: a stomach-directed drug delivery system for misoprostol: Pharmaceutical research, 1992; 9(3):298-302. https://doi.org/10.1023/A:1015870314340
34- Gohel, M. C., Mehta, P. R., Dave, R. K., & Bariya, N. H. A more relevant dissolution method for evaluation of a floating drug delivery system. Dissolution technologies, 2004; 11:22-26. https://doi.org/10.14227/DT110404P22
35- Mayavanshi, A. V., & Gajjar, S. S. Floating drug delivery systems to increase gastric retention of drugs: A Review: Research Journal of Pharmacy and Technology, 2008; 1(4):345-348.
36- Timmermans, J., & Moës, A. J. How well do floating dosage forms float? : International journal of pharmaceutics, 1990; 62(2-3):207-216. https://doi.org/10.1016/0378-5173(90)90234-U
37- Joseph, N. J., Lakshmi, S., & Jayakrishnan, A. A floating-type oral dosage form for piroxicam based on hollow polycarbonate microspheres: in vitro and in vivo evaluation in rabbits: Journal of controlled release, 2002; 79(1-3):71-79. https://doi.org/10.1016/S0168-3659(01)00507-7
38- Avinash, K., Abha, D., Praween, K., & Abhinav, G. Floating drug delivery system a significant tool for stomach specific release of cardiovascular drugs: Int. J. Drug Dev. & Res, 2012; 4(4):116-129.
39- Sarawade, A., Ratnaparkhi, M. P., & Chaudhari, S. Floating drug delivery system: an overview: International Journal of Research and Development in Pharmacy & Life Sciences, 2014; 3(5):1106-1115. https://doi.org/10.22270/jddt.v3i4.579
40- Prajapati, V. D., Jani, G. K., Khutliwala, T. A., & Zala, B. S. Raft forming system-an upcoming approach of gastroretentive drug delivery system: Journal of controlled release, 2013; 168(2):151-165. https://doi.org/10.1016/j.jconrel.2013.02.028
41- Jayanthi G, Jayaswal SB, Srivastava AK. Formulation and evaluation of terfenadine microbaloons for oral controlled release. Pharmazie, 1995; 5:769-770.
42- Devtalu, S. V., Patil, A. E., Bari, M. M., & Barhate, S. D. A Review on Novel Approach-Bi-layer Tablet Technology: Int. J. Pharm. Sci. Rev. Res, 2013; 21(1):46-52.
43- Kumar, M. N. R. A review of chitin and chitosan applications. Reactive and functional polymers, 2000; 46(1):1-27. https://doi.org/10.1016/S1381-5148(00)00038-9
44- Kiang, T., Wen, J., Lim, H. W., & Leong, K. W. The effect of the degree of chitosan deacetylation on the efficiency of gene transfection. Biomaterials, 2004; 25(22):5293-5301. https://doi.org/10.1016/j.biomaterials.2003.12.036
45- Huang, M., Fong, C. W., Khor, E., & Lim, L. Y. Transfection efficiency of chitosan vectors: effect of polymer molecular weight and degree of deacetylation: Journal of controlled release, 2005; 106(3):391-406. https://doi.org/10.1016/j.jconrel.2005.05.004
46- Garud, A., & Garud, N. Preparation and evaluation of chitosan microcapsules of metronidazole using tripolyphosphate cross-linking method: Dhaka University Journal of Pharmaceutical Sciences, 2010; 9(2):125-130. https://doi.org/10.3329/dujps.v9i2.7897
47- Li, X. W., & Yang, T. F. Fabrication of ethyl cellulose microspheres: Chitosan solution as a stabilizer: Korean Journal of Chemical Engineering, 2008; 25(5):1201-1204. https://doi.org/10.1007/s11814-008-0198-8
48- Varshosaz, J., Jaffarian Dehkordi, A., & Golafshan, S. Colon-specific delivery of mesalazine chitosan microspheres: Journal of microencapsulation, 2006; 23(3):329-339. https://doi.org/10.1080/02652040600612405
49- Senthilkumar, S. K., Jaykar, B., & Kavimani, S. Formulation and evaluation of gastroretentive floating drug delivery system of rabeprazole sodium: Int J Biopharm, 2011; 2(2):57-62.
50- Draget, K. I., Skjåk-Bræk, G., & Smidsrød, O. Alginate based new materials: International journal of biological macromolecules, 1997; 21(1-2):47-55. https://doi.org/10.1016/S0141-8130(97)00040-8
51- Kawatra, M., Jain, U., & Ramana, J. Recent advances in floating microspheres as gastro-retentive drug delivery system: A review. Int J Recent Adv Pharm Res, 2012; 2(3):5-23.
52- Dehghan, M., & Kha, F. Gastroretentive drug delivery systems: A patent perspective: International Journal of Health Research, 2009; 2(1). https://doi.org/10.4314/ijhr.v2i1.55385
53- Kshirsagar, S. J., Patil, S. V., & Bhalekar, M. R. Statistical optimization of floating pulsatile drug delivery system for chronotherapy of hypertension. International journal of pharmaceutical investigation, 2011; 1(4):207. https://doi.org/10.4103/2230-973X.93005
54- Bhatt, P., Patel, D., & Chaudhari, R. Formulation and evaluation of floating beads for chronotropic delivery of lornoxicam: World J Pharm Res, 2012; 1:738-56.
55- Yotsuyanagi, T., Ohkubo, T., Ohhashi, T., & Ikeda, K. E. N. Calcium-induced gelation of alginic acid and pH-sensitive reswelling of dried gels. Chemical and Pharmaceutical Bulletin, 1987; 35(4):1555-1563. https://doi.org/10.1248/cpb.35.1555
56- Rowe, R. C., Sheskey, P., & Quinn, M. Handbook of pharmaceutical excipients. Libros Digitales-Pharmaceutical Press. 2009.
57- Ghosal, K., Chakrabarty, S., & Nanda, A. Hydroxypropyl methylcellulose in drug delivery. Der pharmacia sinica, 2011; 2(2):152-168.
58- Barhate, S. D., Rupnar, Y. S., Sonvane, R. M., Pawar, K. R., & Rahane, R. D. Formulation and evaluation of floating microspheres of ketorolac trometamol: Int J Pharm Res Dev, 2009; 1:1-8.
59- Pande, A. V., Vaidya, P. D., Arora, A., & Dhoka, M. V. In vitro and in vivo evaluation of ethyl cellulose based floating microspheres of cefpodoxime proxetil: Int J Pharm Biomed Res, 2010; 1(4):122-128.
60- Joshi, M. Role of eudragit in targeted drug delivery: Int J Curr Pharm Res, 2013; 5(2):58-62.
61- Sonje, A., & Chandra, A. Comprehensive review on Eudragit polymers: Int. Res. J. Pharm, 2013; 4(5):2230-8407. https://doi.org/10.7897/2230-8407.04515
62- Rad, R. T., Jafari-Azar, Z., & Mortazavi, S. A. Formulation and evaluation of captopril floating matrix tablets based on gas formation: African Journal of Pharmacy and Pharmacology, 2013; 7(35):2438-2444. https://doi.org/10.5897/AJPP2013.3531
63- Vandana, P., Nisha, V., Kausalya, J., Vaijayanthi, V., & Ravichandiran, V. Formulation and evaluation of gastro retentive floating tablets of atenolol. 2011.
64- Lende, L. K. L. K., Banerjee, S. K., Gadhave, M. V., Gaikwad, D. D., & Gaykar, A. J. Review on: Bilayer floating tablet: Asian Journal of Pharmaceutical Research and Development, 2013; 31-39.
65- Thakur, S., Ramya, K., Shah, D. K., & Raj, K. Floating Drug Delivery System: Journal of Drug Delivery and Therapeutics, 2021; 11(3-S):125-130. https://doi.org/10.22270/jddt.v11i3-S.4828
66- Jassal, M., Nautiyal, U., Kundlas, J., & Singh, D. A review: Gastroretentive drug delivery system (GRDDS): Indian journal of pharmaceutical and biological research, 2015; 3(01):82-92. https://doi.org/10.30750/ijpbr.3.1.13
67- Ichikawa, M., Watanabe, S., & Miyake, Y. A new multiple-unit oral floating dosage system. I: Preparation and in vitro evaluation of floating and sustained-release characteristics: Journal of pharmaceutical sciences, 1991; 80(11):1062-1066. https://doi.org/10.1002/jps.2600801113
68- Uddin, M., Rathi, P. B., Siddiqui, A. R., Sonawane, A. R., & Gadade, D. D. Recent development in floating delivery systems for gastric retention of drugs an overview: Asian Journal of Biomedical and Pharmaceutical Sciences, 2011; 1(3):26-42.
69- Chueh, H. R., Zia, H., & Rhodes, C. T. Optimization of sotalol floating and bioadhesive extended-release tablet formulations: Drug development and industrial pharmacy, 1995; 21(15):1725-1747. https://doi.org/10.3109/03639049509069261
70- Gu, T. H., Chen, S. X., Zhu, J. B., Song, D. J., Guo, J. Z., & Hou, H. M. Pharmacokinetics and pharmacodynamics of diltiazem floating tablets. Zhongguo yao li xue bao= Acta Pharmacologica Sinica, 1992; 13(6):527-531.
71- Rouge, N., Cole, E. T., Doelker, E., & Buri, P. Buoyancy and drug release patterns of floating minitablets containing piretanide and atenolol as model drugs: Pharmaceutical development and technology, 1998; 3(1):73-84. https://doi.org/10.3109/10837459809028481
72- Ghule, P. N., Deshmukh, A. S., & Mahajan, V. R. Floating Drug Delivery System (FDDS): An Overview: Research Journal of Pharmaceutical Dosage Forms and Technology, 2014; 6(3):174.
73- Rubinstein, A., & Friend, D. R. Specific delivery to the gastrointestinal tract. polymeric site-specific Pharmacotherapy: Wiley, Chichester, 1994; 282-283.
74- Shivhare, U. D., Chilkar, P. M., Bhusari, K. P., & Mathur, V. B. Formulation and Evaluation of Floating Matrix Tablet for Controlled Drug Release: Digest Journal of Nanomaterials and Biostructures, 2011; 6:4-5.
75- Yuvarej ST, Pushpendra SN, Garima RO. Devolpment and evaluation of floating microsperes of verapamil hydrochloride: Brazilian J Pharm Sci 2007; 43:529-34. https://doi.org/10.1590/S1516-93322007000400005
76- Ritschel, W. A. Targeting in the gastrointestinal tract: new approaches: Methods and findings in experimental and clinical pharmacology, 1991; 13(5):313-336.
77- PRABHA, K., Sunil, S., & KUMAR, A. V. Approaches to increase the gastric residence time: floating drug delivery systems-a review: Asian J Pharm Clin Res, 2013; 6(3):1-9.
78- Singh, S., Prajapati, K., Pathak, A. K., & Mishra, A. Formulation and evaluation of floating tablet of captopril: International Journal of Pharm-Tech Research, 2011; 3(1):333-341.
79- Kumari, S. D., Vengatesh, S., Elango, K., Damayanthi, R. D., Deattu, N., & Christina, P. Formulation and evaluation of floating tablets of ondansetron hydrochloride: International Journal of Drug Development & Research: 2012; 4:265-273.
80- Klausner, E. A., Lavy, E., Barta, M., Cserepes, E., Friedman, M., & Hoffman, A. Novel gastro-retentive dosage forms: evaluation of gastro-retentivity and its effect on levodopa absorption in humans: Pharmaceutical research: 2003; 20(9): 1466-1473. https://doi.org/10.1023/A:1025770530084
81- Van Gansbeke, B., Timmermans, J., Schoutens, A., & Moës, A. Intragastric positioning of two concurrently ingested pharmaceutical matrix dosage forms: International journal of radiation applications and instrumentation: 1991; 18(7):711-718. https://doi.org/10.1016/0883-2897(91)90009-A
82- Jao, F., Edgren, D. E., & Wong, P. S. Gastric retention dosage form having multiple layers: Int Application WO0038650: 2006.
83- Hendee, W. R. In Textbook of Diagnostic Imaging II. WB Saunders, Philadelphia: 1999; 1:1-6.
Statistics
80 Views | 1 Downloads
How to Cite
1.
YADAV S, YADAV S, KUMAR A, MISHRA A. Floating Drug Delivery System an Aid to Enhance Dissolution Profile of Gastric. JDDT [Internet]. 15Nov.2021 [cited 1Dec.2021];11(6):286-9. Available from: https://jddtonline.info/index.php/jddt/article/view/5153